Key facts
- This page summarizes Dominic Rodrigues's Form 4 filing for PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 04 Dec 2024, 19:52.
Dominic Rodrigues - 02 Dec 2024 Form 4 Insider Report for PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)
- Reporting relationship
- President, Director
- Issuer ticker
- PVCT
- Reported as of
- 02 Dec 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 Dec 2024, 19:52:57 UTC
- Prior SEC filing
- 30 Sep 2024
- Next SEC filing
- 30 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dominic Rodrigues
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Dominic Rodrigues filed Form 4 for PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) on 04 Dec 2024.
Change
- Previous filing in this sequence was filed on 30 Sep 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PVCT
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +16,146,600
- Change %
- Price
- $0.000000
- Shares after
- 16,146,600
- Date
- 02 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 16,146,600
- Exercise price
- $0.2862
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The options vest in three equal annual installments beginning on December 2, 2024.